Genetics and Pathogenetic Role of Inflammasomes in Philadelphia Negative Chronic Myeloproliferative Neoplasms: A Narrative Review.
Genetics and Pathogenetic Role of Inflammasomes in Philadelphia Negative Chronic Myeloproliferative Neoplasms: A Narrative Review.
复制标题
DOI:
10.3390/ijms22020561
复制
发表时间:
2021-01-08
影响因子:
5.6
通讯作者:
Lucchesi A
中科院分区:
文献类型:
--
作者:
Di Battista V;Bochicchio MT;Giordano G;Napolitano M;Lucchesi A
The last decade has been very important for the quantity of preclinical information obtained regarding chronic myeloproliferative neoplasms (MPNs) and the following will be dedicated to the translational implications of the new biological acquisitions. The overcoming of the mechanistic model of clonal evolution and the entry of chronic inflammation and dysimmunity into the new model are the elements on which to base a part of future therapeutic strategies. The innate immune system plays a major role in this context. Protagonists of the initiation and regulation of many pathological aspects, from cytokine storms to fibrosis, the NLRP3 and AIM2 inflammasomes guide and condition the natural history of the disease. For this reason, MPNs share many biological and clinical aspects with non-neoplastic diseases, such as autoimmune disorders. Finally, cardiovascular risk and disturbances in iron metabolism and myelopoiesis are also closely linked to the role of inflammasomes. Although targeted therapies are already being tested, an increase in knowledge on the subject is desirable and potentially translates into better care for patients with MPNs.
登录
查看更多内容
DOI:
10.1073/pnas.0611496104
发表时间:
2007-05-08
影响因子:
11.1
作者:
Duncan, Joseph A.;Bergstralht, Daniel T.;Ting, Jenny Pan-Yun
通讯作者:
Ting, Jenny Pan-Yun
影响因子:
--
作者:
Eran, Zimran;Zingariello, Maria;Migliaccio, Anna Rita
通讯作者:
Migliaccio, Anna Rita
影响因子:
56.9
作者:
Darnell, JE
通讯作者:
Darnell, JE
影响因子:
3.2
作者:
Durmus, Ahmet;Mentese, Ahmet;Alver, Ahmet
通讯作者:
Alver, Ahmet
影响因子:
20.3
作者:
Fleischman, Angela G.;Aichberger, Karl J.;Deininger, Michael W.
通讯作者:
Deininger, Michael W.